Document:

Restricted Stock Agreement

 Exhibit 4.2 
 Restricted Stock Agreement 
 This Restricted Stock
Agreement (the “Agreement”) is made as of July 30, 2010, by and between Newgistics, Inc., a Delaware corporation (the “Company”) and the Entrepreneurs Foundation of Central Texas, a nonprofit
organization (the “Foundation”). 
 WHEREAS, the Foundation provides opportunities for
the Company to engage in corporate community involvement activities, which may enhance the Company’s reputation and brand, as well as contribute to the betterment of the community; and 

WHEREAS, the Company’s Board of Directors (the “Board”) have adopted resolutions approving
the issuance and donation of the Shares (as defined in Section 1 below) to the Foundation, a copy of which is attached hereto as Exhibit A. 
 NOW THEREFORE, in consideration of the mutual covenants and representations set forth below, the parties agree as follows: 

1. Donation of Shares. On the terms and conditions set forth in this Agreement, the Company hereby issues and
donates to the Foundation 80,000 shares of the Company’s Common Stock (the “Shares”). Such donation shall occur at the offices of the Company on the date set forth above or at such other place and time as the parties may
agree (the “Donation Date”). The Board has determined that the services (the “Services”) rendered to the Company by the Foundation with respect to community involvement on or prior to the date hereof,
including, without limitation, the opportunity to implement a Company donor-advised fund to support future community involvement efforts, as set forth in the form of Donor-Advised Fund Agreement attached hereto as Exhibit B, have a value in
excess of aggregate par value of the Shares. The Company will deliver to the Foundation a certificate representing the donated Shares on the Donation Date and upon such delivery, the Foundation agrees such Shares shall constitute full payment for
the Services. 
 2. Investment Representations. In connection with the donation of the Shares, the
Foundation represents to the Company the following: 
 a. The Foundation is aware of the Company’s
business affairs and financial condition and has acquired sufficient information about the Company to reach an informed and knowledgeable decision with respect to receiving the donation of the Shares. The Foundation is holding the Shares for its
account only and not with a view to, or for resale in connection with, any “distribution” thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”) 

b. The Foundation understands that the Shares have not been registered under the Securities Act by reason of a specific
exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the Foundation’s investment intent as expressed herein. 
 c. The Foundation understands that the Shares are “restricted securities” under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Foundation must hold the
Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Foundation acknowledges that the
Company has no obligation to register or qualify the Shares for resale. The Foundation further acknowledges that that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not
limited to, the time and manner of sale, the holding period for the Shares, and requirements relating to the Company which are outside the Foundation’s control, and which the Company is under no obligation and may be able to satisfy.

 3. Market Standoff. The Foundation agrees that it shall not sell, offer, pledge, contract to sell,
grant any option or contract to purchase, purchase any option or contract to sell, grant any right or warrant to purchase, lend or otherwise transfer or encumber, directly or indirectly, any Shares or other securities of the Company, nor shall the
Foundation enter into any swap, hedging or other arrangement that transfer to another, in whole or in part, any of the economic consequences of ownership of any Shares or other securities of the Company, during the period from the

  
 1 

 
filing of the first registration statement of the Company filed under the Securities Act that includes securities to be sold on behalf of the Company to the public in an underwritten public
offering under the Securities Act through the end of the 180-day period (or such other period as may be requested in writing by the managing underwriter and agreed to in writing by the Company) following the effective date of such registration
statement. The Foundation further agrees, if so requested by the Company or any representative of its underwriters, to enter into such underwriter’s standard form of “lockup” or “market standoff” agreement in a form
satisfactory to the Company and such underwriter. The Company may impose stop-transfer instructions with respect to securities subject to the foregoing restrictions until the end of any such restriction period. 

4. Restrictive Legends and Stop-Transfer Orders. 

a. Legends. The Foundation understands and agrees that the Company shall cause legends set forth below, or
substantially equivalent legends, to be placed upon any certificate(s) evidencing ownership of the Shares, together with any other legends that may be required by the Company or by applicable state or federal securities laws: 

“THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE SUCH ACT AND/OR APPLICABLE STATE SECURITIES LAWS, OR UNLESS THE CORPORATION HAS RECEIVED AN OPINION OF
COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.” 
 “THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON RESALE FOR A PERIOD OF 180 DAYS FROM THE EFFECTIVE DATE OF A REGISTRATION STATEMENT RELATING TO THE COMPANY’S INITIAL
PUBLIC OFFERING.” 
 b. Stop-Transfer Notices. The Foundation agrees that to ensure compliance with
the restrictions referred to herein, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same effect
in its own records. 
 c. Refusal to Transfer. The Company shall not be required (i) to transfer on
its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or (ii) to treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or other
transferee to whom such Shares shall have been so transferred. 
 5. Adjustment for Stock Split. All
reference to the number of Shares and the par value of the Shares in this Agreement shall be appropriately adjusted to reflect any stock split, stock dividend or other change in the Shares which may be made by the Company after the date of this
Agreement. 
 6. Miscellaneous. 

a. Choice of Law. This Agreement shall be governed by the internal substantive laws, but not the choice of law
rules, of Delaware. 
 b. Integration. This Agreement, including all exhibits hereto, represents the
entire agreement between the parties with respect to the purchase of the Shares by the Purchaser and supersedes and replaces any and all prior written or oral agreements regarding the subject matter of this Agreement. 

  
 2 

 c. Notices. Any notice required or permitted by this Agreement
shall be in writing and shall be deemed effectively given the earlier of (i) when received, (ii) when delivered personally, (iii) one business day after being delivered by facsimile (with receipt of appropriate confirmation),
(iv) one business day after being deposited with an overnight courier service or (v) four days after being deposited in the U.S. mail, First Class with postage prepaid and return receipt requested, and addressed to the parties as set forth
below or as subsequently modified by written notice. 
 d. Successor. Any successor to the Company
(whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets shall assume the obligations under the Agreement and agree to expressly
perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under the Agreement, the “Company” shall
include any successor to the Company’s business and/or assets which executes and delivers the assumption agreement described in this section or which becomes bound by the terms of this Agreement by operation of law. Subject to the restrictions
on transfer set forth in this Agreement, this Agreement shall be binding upon the Foundation and its successors and assigns. 
 e. Assignment. The rights and benefits of this Agreement shall inure to the benefit of, and be enforceable by the Company’s successors and assigns. The rights and obligations of the Foundation
under this Agreement may only be assigned with the prior written consent of the Company. 
 f. Waiver.
Either party’s failure to enforce any provision of this Agreement shall not in any way be construed as a waiver of any such provision, nor prevent that party from thereafter enforcing any other provision of this Agreement. The rights granted
both parties hereunder are cumulative and shall not constitute a waiver of either party’s right to assert any other legal remedy available to it. 
 g. Severability. Should any provision of this Agreement be found to be illegal or unenforceable, the other provisions shall nevertheless remain effective and shall remain enforceable to the
greatest extent permitted by law. 
 h. Construction. This Agreement is the result of negotiations
between and has been reviewed by each of the parties hereto and their respective counsel, if any; accordingly, this Agreement shall be deemed to the product of all of the parties hereto, and no ambiguity shall be construed in favor of or against any
one of the parties hereto. 
 i. Counterparts. This Agreement may be executed in one or more
counterparts, each of which will deemed an original, but all of which together will constitute one and the same agreement. Facsimile copies of the signed signature pages shall be binding originals. 

[Signature page follows] 

  
 3 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
first set forth above. 
  

			
	 “Company”

	
	 Newgistics, Inc.

		
	 By:
	 	 /s/ Michael J. Twomey

		 	 Michael J. Twomey

		 	 Chief Financial Officer

			
		
	 Address:
	 	 2700 Via Fortuna, Suite 300

		 	 Austin, Texas 78746

			
		
	 “Foundation”
	 	
	
	 Entrepreneurs Foundation of Central Texas

			
		
	 By:
	 	 /s/ Eugene
Sepulveda

			
		
	 Name:
	 	
CEO

			
		
	 Title:
	 	
 

			
		
	 Address:
	 	  

	
	  

Restricted Stock Agreement 
 Signature Page 

  
 4 

 Exhibit A 
 Board Resolutions 
 Approving Donation of Shares to the Foundation 

WHEREAS: The Board has deemed it to be in the best interests of the Company to contribute to the betterment of the community by
making a charitable donation of the Company’s common stock to the Entrepreneurs Foundation of Central Texas (“Foundation”), a non-profit organization, with the goal that an increase in the value of the Company also serve
to benefit charitable organizations. 
 NOW, THEREFORE, BE IT RESOLVED: That the Company is authorized to issue and grant
80,000 shares of its common stock, par value $0.001 (the “Shares”) to the Foundation on the terms and conditions set forth in the Restricted Stock Agreement, which agreement has been provided to and reviewed by the Board.

 RESOLVED FURTHER: That the Shares, when issued in accordance with the terms of the Restricted Stock Agreement shall be
validly issued, fully paid and nonassessable. 
 RESOLVED FURTHER: That the Company’s Chief Financial Officer
is authorized to take such actions as such officer considers necessary to carry out these resolutions. 

  
 5 

 Exhibit B 
 Donor-Advised Fund Agreement 

  
 6 

 DONOR-ADVISED FUND AGREEMENT 

This Donor-Advised Fund Agreement (the “Agreement”) is made as of July 30, 2010 by and
between Newgistics, Inc., a Delaware corporation (the “Company”) and the Entrepreneurs Foundation of Central Texas, a non-profit organization (the “Foundation”). 

WHEREAS, the Company desires to contribute to the betterment of the community by making a charitable donation of 80,000
shares of Company common stock to the Foundation (the “Equity Donation”) as set forth in that certain Restricted Stock Agreement executed by and between the Company and Foundation on or about the date hereof. 

NOW THEREFORE, in consideration of the foregoing, the parties hereby agree as follows: 

 

	 	1.	 Foundation Member Company Benefits: The Company’s Equity Donation qualifies it as a member of the Foundation. The benefits of membership
include, but are not limited to, the Foundation: 

  

	 	a.	 Consulting with the Company to determine areas of interest for the Company’s community involvement; 

 

	 	b.	 Presenting community-based organizations or projects to the Company for review and possible selection as potential targets for Company donations;

  

	 	c.	 Linking the Company with community service projects such that the Company builds a presence in the community and gains recognition for innovative
community investment; and 

  

	 	d.	 Providing feedback and evaluation on the outcomes of community involvement projects. 

 

	 	2.	 Donor-Advised Fund: The Company and the Foundation hereby acknowledge and agree that: 

 

	 	a.	 All contributions to the Foundation shall be irrevocable and shall be used in furtherance of the charitable and philanthropic purposes of the
Foundation. At any time prior to the disposition of the sale of shares arising from the Equity Donation, the Company may advise the Foundation regarding the charitable and philanthropic disposition of up to [eighty percent (80%)] of the proceeds
from the sale of the shares arising from the Equity Donation with a non-binding written or oral recommendation. The remaining [twenty percent (20%)] will become part of the Foundation’s general fund and shall be used to pay general expenses of
the Foundation. 

  

	 	b.	 Notwithstanding anything in this agreement to the contrary, the Foundation shall, in its sole discretion, determine and distribute the proceeds from
the sale of the shares arising from the Equity Donation in furtherance of the purposes of the Foundation and that there will be no financial benefit to the Company, nor will there be a distribution of proceeds to a private non-operating foundation.

  

	 	c.	 In the event that the Foundation should determine that the continued compliance with the terms of this Agreement would be impossible or impractical
or the Foundation ceases to exist or otherwise ceases to function, the Foundation shall distribute the net assets of this contribution to one or more charitable organizations exempt from taxation under Section 501(c)(3) of the Internal Revenue
Code of 1986, as amended. 

  

	 	d.	 The Foundation shall incur no liability to the undersigned for anything done, or omitted by the Foundation in connection with the Foundation’s
duties hereunder, except for loss occasioned by the gross negligence or bad faith of Foundation and each of the parties to this agreement specifically acknowledge that the Foundation is not acting as a trustee with respect to the arrangement set
forth in this Agreement. 

 [Signature Page to follow] 

  
 7 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
first set forth above. 
  

			
	 “Company”

		
	 Newgistics
	 	

			
		
	 By:
	 	  

		 	 Michael J. Twomey

		 	 Chief Financial Officer

			
		
	 Address:
	 	 2700 Via Fortuna, Suite 300

		 	 Austin, Texas 78746

			
		
	 “Foundation”
	 	
	
	 Entrepreneurs Foundation of Central Texas

			
		
	 By:
	 	
 

			
		
	 Name:
	 	
 

			
		
	 Title:
	 	
 

			
		
	 Address:
	 	  

	
	  

Donor-Advised Fund Agreement 
 Signature Page 

  
 8Amended and Restated Warrant to purchase Preferred Stock

 Exhibit 4.3 
 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED
WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED. 

AMENDED AND RESTATED WARRANT TO PURCHASE STOCK 
 Corporation: Newgistics, Inc., a Delaware Corporation 
 Number of Shares: 10,000 

Class of Stock: Series A Preferred Stock 

Initial Exercise Price: $0.50 per share 
 Issue
Date: July 25,2000 
 Expiration Date: May 15,2007 (Subject to Article 4.1) 

THIS WARRANT CERTIFIES THAT, in consideration of the payment of $1.00 and for other good and valuable consideration, IMPERIAL BANCORP or
registered assignee (“Holder”) is entitled to purchase the number of fully paid and nonassessable shares of the class of securities (the “Shares”) of the corporation (the “Company”) at the initial exercise price per
Share (the “Warrant Price”) all as set forth above and as adjusted pursuant to Article 2 of this Warrant, subject to the provisions and upon the terms and conditions set forth of this Warrant. 

ARTICLE 1. EXERCISE 
 1.1 Method of Exercise. Holder may exercise this Warrant by delivering this Warrant and a duly executed Notice of Exercise in substantially the form attached as Appendix 1 to the principal office of the
Company. Unless Holder is exercising the conversion right set forth in Section 1.2, Holder shall also deliver to the Company a check for the aggregate Warrant Price for the Shares being purchased. 

1.2 Conversion Right. In lieu of exercising this Warrant as specified in Section 1.1, Holder may from time to time convert this
Warrant, in whole or in part, into a number of Shares determined by dividing (a) the aggregate fair market value of the Shares or other securities otherwise issuable upon exercise of this Warrant minus the aggregate Warrant Price of such Shares
by (b) the fair market value of one Share. The fair market value of the Shares shall be determined pursuant to Section 1.5. 
 1.3 [Intentionally Omitted.] 
 1.4 [Intentionally Omitted.]

 1.5 Fair Market Value. If the Shares are traded regularly in a public market, the fair market value of the Shares shall be
the closing price of the Shares (or the closing price of the Company’s stock into which the Shares are convertible) reported for the business day immediately before Holder delivers its Notice of Exercise to the Company. If the Shares are not

  
 1 

 
regularly traded in a public market, the Board of Directors of the Company shall determine fair market value in its reasonable good faith judgment. The foregoing notwithstanding, if Holder
advises the Board of Directors in writing that Holder disagrees with such determination, then the Company and Holder shall promptly agree upon a reputable investment banking firm to undertake such valuation. If the valuation of such investment
banking firm is greater than that determined by the Board of Directors, then all fees and expenses of such investment banking firm shall be paid by the Company. In all other circumstances, such fees and expenses shall be paid by Holder. 

1.6 Delivery of Certificate and New Warrant. Promptly after Holder exercises or converts this Warrant, the Company shall deliver to
Holder certificates for the Shares acquired and, if this Warrant has not been fully exercised or converted and has not expired, a new Warrant representing the Shares not so acquired. 

1.7 Replacement of Warrants. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation
of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and amount to the Company or, in the case of mutilation, or surrender and cancellation of this Warrant, the Company
at its expense shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor. 
 1.8 Repurchase on Sale,
Merger, or Consolidation of the Company. 
 1.8.1. “Acquisition”. For the purpose of this Warrant,
“Acquisition” means any sale, license, or other disposition of all or substantially all of the assets (including intellectual property) of the Company, or any reorganization, consolidation, or merger of the Company where the holders of the
Company’s securities before the transaction beneficially own less than 50% of the outstanding voting securities of the surviving entity after the transaction. 
 1.8.2. Assumption of Warrant. If upon the closing of any Acquisition the successor entity assumes the obligations of this Warrant, then this Warrant shall be exercisable for the same securities, cash, and
property as would be payable for the Shares issuable upon exercise of the unexercised portion of this Warrant as if such Shares were outstanding on the record date for the Acquisition and subsequent closing. The Warrant Price shall be adjusted
accordingly. The Company shall use reasonable efforts to cause the surviving corporation to assume the obligations of this Warrant. 
 1.8.3. Nonassumption. If upon the closing of any Acquisition the successor entity does not assume the obligations of this Warrant and Holder has not otherwise exercised this Warrant in full, then the
unexercised portion of this Warrant shall be deemed to have been automatically converted pursuant to Section 1.2 and thereafter Holder shall participate in the Acquisition on the same terms as other holders of the same class of securities of
the Company. 
 1.8.4. Purchase Right. Notwithstanding the foregoing, at the election of Holder, the Company shall purchase the
unexercised portion of this Warrant for cash upon the closing of any Acquisition for an amount equal to (a) the fair market value of any consideration that would have been received by Holder in consideration of the Shares had Holder exercised
the unexercised 

  
 2 

 
portion of this Warrant immediately before the record date for determining the shareholders entitled to participate in the proceeds of the Acquisition, less (b) the aggregate Warrant Price
of the Shares, but in no event less than zero. 
 ARTICLE 2. ADJUSTMENTS TO THE SHARES. 

2.1 Stock Dividends, Splits, Etc. If the Company declares or pays a dividend on its common stock payable in common stock, or other
securities, subdivides the outstanding common stock into a greater amount of common stock, then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without cost to Holder, the total number and kind of securities to which
Holder would have been entitled had Holder owned the Shares of record as of the date the dividend-or-subdivision. occurred. 

2.2 Reclassification, Exchange or Substitution. Upon any reclassification, exchange, substitution, or other event that results in a
change of the number and/or class of the securities issuable upon exercise or conversion of this Warrant, Holder shall be entitled to receive, upon exercise or conversion of this Warrant, the number and kind of securities and property that Holder
would have received for the Shares if this Warrant had been exercised immediately before such reclassification, exchange, substitution, or other event. Such an event shall include any automatic conversion of the outstanding or issuable securities of
the Company of the same class or series as the Shares to common stock pursuant to the terms of the Company’s Articles of Incorporation upon the closing of a registered public offering of the Company’s common stock. The Company or its
successor shall promptly issue to Holder a new Warrant for such new securities or other property. The new Warrant shall provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided for in this Article
2 including, without limitation, adjustments to the Warrant Price and to the number of securities or property issuable upon exercise of the new Warrant. The provisions of this Section 2.2 shall similarly apply to successive reclassifications,
exchanges, substitutions, or other events. 
 2.3 Adjustments for Combinations, Etc. If the outstanding Shares are combined or
consolidated, by reclassification or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased. 
 2.4 Adjustments for Diluting Issuances. The Warrant Price and the number of Shares issuable upon exercise of this Warrant shall be subject to adjustment, from time to time, in the manner set forth on
Exhibit A, in the event of Diluting Issuances (as defined on Exhibit A). 
 2.5 No Impairment. The Company shall not, by
amendment of its Certificate of Incorporation or through a reorganization, transfer of assets, consolidation, merger, dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of
any of the terms to be observed or performed under this Warrant by the Company, but shall at all times in good faith assist in carrying out all the provisions of this Article 2 and in taking all such action as may be necessary or appropriate to
protect Holder’s rights under this Article against impairment. If the Company takes any action affecting the Shares or its common stock other than as described above that adversely affects Holder’s rights under this Warrant, the Warrant
Price shall be adjusted downward and the number of Shares issuable upon exercise of this Warrant shall be adjusted upward in such a manner that the 

  
 3 

 
aggregate Warrant Price of this Warrant is unchanged. 
 2.6 Certificate
as to Adjustments. Upon each adjustment of the Warrant Price, the Company at its expense shall promptly compute such adjustment, and furnish Holder with a certificate of its Chief Financial Officer setting forth such adjustment and the facts upon
which such adjustment is based. The Company shall, upon written request, furnish Holder a certificate setting forth the Warrant Price in effect upon the date thereof and the series of adjustments leading to such Warrant Price, 

ARTICLE 3. REPRESENTATIONS AND COVENANTS OF THE COMPANY. 
 3.1 Representations and Warranties. -The Company hereby .represents and warrants to the Holder as follows: 
 (a) The initial Warrant Price referenced on the first page of this Warrant is equal to the price at which the company is selling its Series A Preferred Stock to investors on or about the date of this
warrant. 
 (b) All Shares which may be issued upon the exercise of the purchase right represented by this Warrant, and all
securities, if any, issuable upon conversion of the Shares, shall, upon issuance, be duly authorized, validly issued, fully paid and nonassessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein or
under applicable federal and state securities laws. 
 3.2 Notice of Certain Events. If the Company proposes at any time
(a) to declare any dividend or distribution upon its common stock, whether in cash, property, stock, or other securities and whether or not a regular cash dividend; (b) to offer for subscription pro rata to the holders of any class or
series of its stock any additional shares of stock of any class or series or other rights; (c) to effect any reclassification or recapitalization of common stock; (d) to merge or consolidate with or into any other corporation, or sell,
lease, license, or convey all or substantially all of its assets, or to liquidate, dissolve or wind up; or (e) offer holders of registration rights the opportunity to participate in an underwritten public offering of the company’s
securities for cash, then, in connection with each such event, the Company shall give Holder (1) at least 20 days prior written notice of the date on which a record will be taken for such dividend, distribution, or subscription rights (and
specifying the date on which the holders of common stock will be entitled thereto) or for determining rights to vote, if any, in respect of the matters referred to in (c) and (d) above; (2) in the case of the matters referred to in
(c) and (d) above at least 20 days prior written notice of the date when the same will take place (and specifying the date on which the holders of common stock will be entitled to exchange their common stock for securities or other
property deliverable upon the occurrence of such event); and (3) in the case of the matter referred to in (e) above, the same notice as is given to the holders of such registration rights. 

3.3 Information Rights. So long as the Holder holds this Warrant and/or any of the Shares, the Company shall deliver to the Holder
(a) promptly after mailing, copies of all communiques to the shareholders of the Company, (b) within one hundred twenty (120) days after the end of each fiscal year of the Company, the annual audited financial statements of the

  
 4 

 
Company certified by independent public accountants of recognized standing and (c) within forty-five (45) days after the end of each of the first three quarters of each fiscal year, the
Company’s quarterly, unaudited financial statements. 
 3.4 Registration Under Securities Act of 1933, as amended. The
Company agrees that upon its issuance of Series A preferred stock, the Shares shall be subject to the registration rights set forth on Exhibit B. 
 ARTICLE 4. MISCELLANEOUS. 
 4.1 Term: Notice of Expiration. This Warrant is
exercisable, in whole or in part, at any time and from time to time on or before the Expiration Date set forth above. The Company shall give Holder written notice of Holder’s right to exercise this Warrant in the form attached as Appendix 2 not
more than 90 days and not less than 30 days before the Expiration Date. If the notice is not so given, the Expiration Date shall automatically be extended until 30 days after the date the Company delivers the notice to Holder. 

4.2 Legends. This Warrant and the Shares (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any)
shall be imprinted with a legend in substantially the following form: 
 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR LAWS OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO THE CORPORATION AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED. 
 4.3 Compliance with Securities Laws
on Transfer. This Warrant and the Shares issuable upon exercise this Warrant (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any) may not be transferred or assigned in whole or in part without compliance with
applicable federal and state securities laws by the transferor and the transferee (including, without limitation, the delivery of investment representation letters and legal opinions reasonably satisfactory to the Company). The Company shall not
require Holder to provide an opinion of counsel if the transfer is to an affiliate of Holder or if there is no material question as to the availability of current information as referenced in Rule 144(c), Holder represents that it has complied with
Rule 144(d) and (e) in reasonable detail, the selling broker represents that it has complied with Rule 144(f), and the Company is provided with a copy of Holder’s notice of proposed sale. 

4.4 Transfer Procedure. Subject to the provisions of Section 4.3, Holder may transfer all or part of this Warrant or the Shares
issuable upon exercise of this Warrant (or the securities issuable, directly or indirectly, upon conversion of the Shares, if any) by giving the Company notice of the portion of the Warrant being transferred setting forth the name, address and
taxpayer identification number of the transferee and surrendering this Warrant to the Company for reissuance to the transferee(s) (and Holder, if applicable). Unless the Company is filing financial information with the SEC pursuant to the Securities
Exchange Act of 1934, the 

  
 5 

 
Company shall have the right to refuse to transfer any portion of this Warrant to any person who directly competes with the Company. 

4.5 Notices. All notices and other communications from the Company to the Holder, or vice versa, shall be deemed delivered and effective
when given personally or mailed by first-class registered or certified mail, postage prepaid, at such address as may have been furnished to the Company or the Holder, as the case may be, in writing by the Company or such Holder from time to time.

 4.6 Waiver. This Warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in
writing signed by the party against which enforcement of such change, waiver, discharge or termination is sought. 
 4.7
Attorneys’ Fees. In the event of any dispute between the parties concerning the terms and provisions of this Warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute,
including reasonable attorneys’ fees. 
 4.8 Governing Law. This Warrant shall be governed by and construed in accordance
with the laws of the State of California, without giving effect to its principles regarding conflicts of law. 
 Newgistics, Inc.

  

									
	 By:
	 	 /s/ Clarence Gabriel
	 		 	By:	 	 /s/ Edward J. Stashlikle

					
	 Name:
	 	 Clarence Gabriel
	 		 	Name:	 	 Edward J. Stashlikle

					
	 Title:
	 	 CEO
	 		 	Title:	 	  

  
 6 

 APPENDIX 1 NOTICE OF EXERCISE 

1. The undersigned hereby elects to purchase              shares of
the              Stock of Newgistics, Inc. pursuant to the terms of the attached Warrant, and tenders herewith payment of the purchase price of such shares in full. 

1. The undersigned hereby elects to convert the attached Warrant into Shares in the manner specified in the Warrant. This conversion is
exercised with respect to              of the Shares covered by the Warrant. 
 [Strike paragraph that does not apply.] 
 2. Please issue a certificate or
certificates representing said shares in the name of the undersigned or in such other name as is specified below: 
 Imperial
Bancorp 
 c/o Controllers Department 
 P.O. Box 92991 
 Los Angeles, CA 90009 

Or Registered Assignee 
 3. The undersigned represents it is acquiring the shares solely for its own account and not as a nominee for any other party and not with a view toward the resale or distribution thereof except in
compliance with applicable securities laws. 
  

	
	 IMPERIAL BANCORP or Registered Assignee

	
	  

	 (Signature)

	
	  

	(Date)

  
 7 

 APPENDIX 2 
 NOTICE THAT WARRANT IS ABOUT TO EXPIRE 

            ,
             
 Chief Financial Officer 

Controllers Department 
 Imperial Bancorp 
 P.O. Box 92991 

Los Angeles, CA 90009 
 Or Registered Assignee 
 Gentleperson: 

This is to advise you that the Warrant issued to you described below will expire on
            . 
 Issuer: Newgistics, Inc. 

Issue Date: May 15,2000 
 Class of Security Issuable: 
 Exercise Price Per Share: Price 

Number of Shares Issuable: Number of Shares 
 Procedure for Exercise: 
 Please contact [name of contact person at (phone
number)] with any questions you may haveconcerning exercise of the Warrant. This is your only notice of pending expiration. 
  

					
		 	 Newgistics, Inc.

			
		 	 By:
	 	  

			
		 	 Its:
	 	  

  
 8 

 EXHIBIT A 
 Anti-Dilution Provisions 
 (For Preferred Stock Warrants with Existing Anti-Dilution
Protection) 
 In the event of the issuance (a “Diluting Issuance”) by the Company, after the Issue Date of the
warrant, of securities at a price per share less than the Warrant Price, then the number of shares of common stock issuable upon conversion of the Shares shall be adjusted in accordance with those provisions (the “Provisions’) of the
Company’s Certificate of Incorporation which apply to Diluting Issuances. 
 Under no circumstances shall the aggregate
Warrant Price payable by the Holder upon exercise of the warrant increase as a result of any adjustment arising from a Diluting Issuance. 

  
 9 

 EXHIBIT B 
 Registration Rights 
 The Shares shall be deemed “registrable
securities” or otherwise entitled to “piggy back” registration rights in accordance with the terms of the following agreement (the “Agreement”) between the Company and its investor(s): 

Investor’s Rights Agreement dated July 25, 2000 between Company and Investors listed on schedule A thereto. 

The Company agrees that no amendments will be made to the Agreement which would have an adverse impact on Holder’s registration
thereunder without the consent of Holder. By acceptance of the Warrant to which this Exhibit B is attached, Holder shall not be deemed to be a party to the Agreement, but solely entitled to the registration rights created thereby. 

  
 10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}]]